Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer

• Main Authors: Imjai Chitapanarux, Pimkhuan Kamnerdsupaphon, Nantaka Pukanhapan, Ekkasit Tharavichitkul, Roy Vongtama
• 格式: 雜誌
• 出版: 2018
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84888263886&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/47534
• 機構: Chiang Mai University

The aim of this study was to compare the efficacy and safety of concurrent chemoradiotherapy (CCRT) vs accelerated hyperfractionation with concomitant boost (CCB) as a primary treatment for patients with Stage 3-5 squamous cell carcinoma of head and neck (SCCHN). A total of 85 non-metastatic advance...